These studies in GEA, corroborated by similar results found for ovarian cancer [24], highlighted that low or complete lack of p53 IHC staining may be considered aberrant and that IHC alone underestimates the frequency of CIN cases. This evidence concerns the gene TP53 and ovarian carcinoma.